Publications by authors named "Curtis Scribner"

Claim this Profile
P
Phase 2 Dose-Ranging Trial of VGT-309 for Molecular Imaging of Cancer during Pulmonary Resection.
Gavin M Wright, A J Matthew Egan, Jane M Mack, Sharnel Clatworthy, Rafaela Anja, Curtis L Scribner

Eur J Cardiothorac Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b randomised clinical trial evaluating BBI-001, a non-absorbed oral therapeutic for the treatment of iron overload.
Curtis Scribner, Jamie Cope, Philip Ryan, John K Olynyk, John Ryan

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play.
Lyn R Frumkin, Michaela Lucas, Michael Wallach, Curtis L Scribner, Tom St John

J Glob Health· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.
Lyn R Frumkin, Michaela Lucas, Curtis L Scribner, Nastassja Ortega-Heinly, Jayden Rogers

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RRx-001, a downregulator of the CD47- SIRPα checkpoint pathway, does not cause anemia or thrombocytopenia.
Bryan Oronsky, Pedro Cabrales, Scott Caroen, Xiaoning Guo, Curtis Scribner

Expert Opin Drug Metab Toxicol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020.
Ying Kai Chan, Andrew D Dick, Sara Mary Hall, Thomas Langmann, Curtis L Scribner

Transl Vis Sci Technol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial.
Viola Klück, Tim L Th A Jansen, Matthijs Janssen, Antoaneta Comarniceanu, Monique Efdé, Curtis L Scribner

Lancet Rheumatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic".
Bryan Oronsky, Corey A Carter, Scott Caroen, Curtis Scribner, Arnold Oronsky

Oncoimmunology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer.
Bryan Oronsky, Tony R Reid, Christopher Larson, Scott Caroen, Mary Quinn, Curtis L Scribner

Future Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibition.
Bryan Oronsky, Curtis Scribner, Rahul Aggarwal, Pedro Cabrales

J Cancer Res Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Carlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, Charles P Neff, Katrin Richter, Curtis L Scribner

Proc Natl Acad Sci U S A· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
Victor E Buckwold, Jiayi Wei, Zhuhui Huang, Chunsheng Huang, Aysegul Nalca, Curtis Scribner

Antiviral Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.
Victor E Buckwold, William Lang, Curtis Scribner, Dennis Blanchett, Tom Alessi

Basic Clin Pharmacol Toxicol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis